Accelerate to discover
Related topics
Cell plasticity associated to circulating tumor cells from prostate cancer patients
Mar 13, 2019
Treatment resistance is associated with tumor cells molecular plasticity. In metastatic castration resistant prostate...
Monitoring cancer treatments with immuno-PET webinar
Mar 8, 2019
In this webinar, Dr Gabriela Kramer-Marek, Team Leader in Preclinical Molecular Imaging The Institute of Cancer...
Izon qEV - The fastest & most effective Exosome isolation
Mar 6, 2019
Extracellular vesicles (EVs) are prevalent in biological fluids and are of great interest to researchers ...
Enhanced uptake of luminescent quantum dots by live cells
Mar 1, 2019
The steady progress made over the past threedecades in growing a variety of inorganic nanomaterials, with discreet...
Fat-water separation Imaging in Preclinical MRI
Mar 1, 2019
Non-invasive in vivo phenotyping of adipose tissue deposits in small animal models is of great importance in...
Feb 15, 2019
The CellRad system allows you to irradiate cells in your lab without compromising sterility or security. A smaller,...
New technique for dynamic monitoring of liquid tumor Cytotoxicity
Feb 12, 2019
To develop and validate immuno-oncology therapies, scientists must understand the full dynamics of cytotoxic effectors...
Small animal 13C-hyperpolarized MRI
Feb 8, 2019
13C-Hyperpolarized molecules provide a unique signature for molecular processes relevant to a range of disease...
Mar 22, 2016
The mutations driving cancer create clonal populations that differ not just between cancer patients, but within individual tumors. These mutations contain small but significant populations which may survive treatment and metastasize. The only method to get a complete picture of tumor clonality is by sequencing single cells.
In this webinar, you will learn how you can make breakthrough discoveries in your research using single-cell DNA Sequencing. Dr. Ioannis Ragoussis of McGill University will share his research using single-cell whole exome sequencing to reveal the true heterogeneity and cell lineages present in triple negative breast cancer.
Brand profile
Fluidigm is a Molecular and Single Cell Biology company that creates microfluidic-based chips and instrumentation for Life-Science research.
More info at:
www.fluidigm.com/
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
